CNTN4 as a novel target for solid cancer with antibody-drug conjugate

被引：0
|
作者：
Cha, Mi Young
Kim, Hyunuk
Byun, Seungmin
Ha, Youngeun
Park, Kitae
Yu, Hyunkyung
Jeon, Bu-Nam
Kim, Mira
Moon, Soojung
Park, Kyung Mi
Park, Hansoo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-740
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
740
引用
收藏
页数：2
相关论文
共 50 条
  • [11] A Novel c-MET-Targeting Antibody-Drug Conjugate for Pancreatic Cancer
    Jin, Yangbing
    Zhang, Zehui
    Zou, Siyi
    Li, Fanlu
    Chen, Hao
    Peng, Chenghong
    Deng, Xiaxing
    Wen, Chenlei
    Shen, Baiyong
    Zhan, Qian
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [12] Antibody-Drug Conjugate Targets
    Teicher, B. A.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (08) : 982 - 1004
  • [13] An Immunosuppressive Antibody-Drug Conjugate
    Wang, Rongsheng E.
    Liu, Tao
    Wang, Ying
    Cao, Yu
    Du, Jintang
    Luo, Xiaozhou
    Deshmukh, Vishal
    Kim, Chan Hyuk
    Lawson, Brian R.
    Tremblay, Matthew S.
    Young, Travis S.
    Kazane, Stephanie A.
    Wang, Feng
    Schultz, Peter G.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2015, 137 (09) : 3229 - 3232
  • [14] The antibody-drug conjugate landscape
    Flynn, Patrick
    Suryaprakash, Smruthi
    Grossman, Dan
    Panier, Val
    Wu, John
    NATURE REVIEWS DRUG DISCOVERY, 2024, 23 (08) : 577 - 578
  • [15] Lung cancer treatment with antibody-drug conjugate (ADC)
    Hotta, Katsuyuki
    CANCER SCIENCE, 2018, 109 : 818 - 818
  • [16] Antibody-drug conjugate against breast cancer approved
    不详
    BIOENGINEERED, 2013, 4 (03) : 121 - 121
  • [17] Research Trend of Publications Concerning Antibody-Drug Conjugate in Solid Cancer: A Bibliometric Study
    Qi, Xiangjun
    Li, Yanlong
    Liu, Wei
    Wang, Yifan
    Chen, Zhuangzhong
    Lin, Lizhu
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [18] Recent progress in antibody-drug conjugate therapy for cancer
    Hurvitz, Sara A.
    NATURE CANCER, 2022, 3 (12) : 1412 - 1413
  • [19] Novel immune checkpoint protein CNTN4 and the preclinical efficacy of affinity matured anti-CNTN4 antibody GENA-104A16
    Cha, Mi Young
    Yu, Hyunkyung
    Jeon, Bu-Nam
    Kim, Hyunuk
    Ha, Youngeun
    Kim, Yunyeon
    Chung, Joo-Yeon
    Moon, Soojung
    Youn, Hyunseong
    Kim, Han-sol
    Park, Kyung Mi
    Park, Hansoo
    CANCER RESEARCH, 2022, 82 (12)
  • [20] Target validation, antibody discovery and preclinical data supporting ADAM9 as an antibody-drug conjugate therapeutic target for solid tumors
    Scribner, Juniper A.
    Barat, Bhaswati
    Hicks, Stuart W.
    Yoder, Nicholas C.
    Son, Thomas
    Widjaja, Lusiana
    Diedrich, Gundo
    Gorlatov, Sergey
    Hooley, Jeff
    Easton, Ann
    Lung, Peter
    De Costa, Anushka
    Chen, Francine
    Chiechi, Michael
    Li, Pam
    Licea, Monica
    Hotaling, Timothy E.
    Spliedt, Michael
    Ciccarone, Valentina
    Gantt, Nadia
    Tamura, James
    Fuller, Megan E.
    McShea, Molly
    Koenig, Scott
    Johnson, Syd
    Moore, Paul A.
    Bonvini, Ezio
    Loo, Deryk
    CANCER RESEARCH, 2017, 77
12345